Literature DB >> 30275015

Codon usage regulates human KRAS expression at both transcriptional and translational levels.

Jingjing Fu1, Yunkun Dang2, Christopher Counter3, Yi Liu4.   

Abstract

KRAS and HRAS are highly homologous oncogenic Ras GTPase family members that are mutated in a wide spectrum of human cancers. Despite having high amino acid identity, KRAS and HRAS have very different codon usage biases: the HRAS gene contains many common codons, and KRAS is enriched for rare codons. Rare codons in KRAS suppress its protein expression, which has been shown to affect both normal and cancer biology in mammals. Here, using HRAS or KRAS expression in different human cell lines and in vitro transcription and translation assays, we show that KRAS rare codons inhibit both translation efficiency and transcription and that the contribution of these two processes varies among different cell lines. We observed that codon usage regulates mRNA translation efficiency such that WT KRAS mRNA is poorly translated. On the other hand, common codons increased transcriptional rates by promoting activating histone modifications and recruitment of transcriptional coactivators. Finally, we found that codon usage also influences KRAS protein conformation, likely because of its effect on co-translational protein folding. Together, our results reveal that codon usage has multidimensional effects on protein expression, ranging from effects on transcription to protein folding in human cells.
© 2018 Fu et al.

Entities:  

Keywords:  C content; GTPase Kras (KRAS); chromatin regulation; codon optimization; codon usage bias; oncogene; oncogenesis; protein folding; transcription; translation

Mesh:

Substances:

Year:  2018        PMID: 30275015      PMCID: PMC6240855          DOI: 10.1074/jbc.RA118.004908

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Codon usage tabulated from international DNA sequence databases: status for the year 2000.

Authors:  Y Nakamura; T Gojobori; T Ikemura
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Differences in codon bias and GC content contribute to the balanced expression of TLR7 and TLR9.

Authors:  Zachary R Newman; Janet M Young; Nicholas T Ingolia; Gregory M Barton
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-22       Impact factor: 11.205

Review 3.  Drugging the undruggable RAS: Mission possible?

Authors:  Adrienne D Cox; Stephen W Fesik; Alec C Kimmelman; Ji Luo; Channing J Der
Journal:  Nat Rev Drug Discov       Date:  2014-10-17       Impact factor: 84.694

4.  Codon identity regulates mRNA stability and translation efficiency during the maternal-to-zygotic transition.

Authors:  Ariel A Bazzini; Florencia Del Viso; Miguel A Moreno-Mateos; Timothy G Johnstone; Charles E Vejnar; Yidan Qin; Jun Yao; Mustafa K Khokha; Antonio J Giraldez
Journal:  EMBO J       Date:  2016-07-19       Impact factor: 11.598

5.  The codon Adaptation Index--a measure of directional synonymous codon usage bias, and its potential applications.

Authors:  P M Sharp; W H Li
Journal:  Nucleic Acids Res       Date:  1987-02-11       Impact factor: 16.971

6.  All three human ras genes are expressed in a wide range of tissues.

Authors:  G Fiorucci; A Hall
Journal:  Biochim Biophys Acta       Date:  1988-05-06

7.  The silent codon change I507-ATC->ATT contributes to the severity of the ΔF508 CFTR channel dysfunction.

Authors:  Ahmed Lazrak; Lianwu Fu; Vedrana Bali; Rafal Bartoszewski; Andras Rab; Viktoria Havasi; Steve Keiles; John Kappes; Ranjit Kumar; Elliot Lefkowitz; Eric J Sorscher; Sadis Matalon; James F Collawn; Zsuzsanna Bebok
Journal:  FASEB J       Date:  2013-08-01       Impact factor: 5.191

8.  Wild-type Kras expands and exhausts hematopoietic stem cells.

Authors:  Joshua P Sasine; Heather A Himburg; Christina M Termini; Martina Roos; Evelyn Tran; Liman Zhao; Jenny Kan; Michelle Li; Yurun Zhang; Stéphanie C de Barros; Dinesh S Rao; Christopher M Counter; John P Chute
Journal:  JCI Insight       Date:  2018-06-07

9.  Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance.

Authors:  Moiez Ali; Erin Kaltenbrun; Gray R Anderson; Sarah Jo Stephens; Sabrina Arena; Alberto Bardelli; Christopher M Counter; Kris C Wood
Journal:  Nat Commun       Date:  2017-06-08       Impact factor: 14.919

10.  A comprehensive survey of Ras mutations in cancer.

Authors:  Ian A Prior; Paul D Lewis; Carla Mattos
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

View more
  22 in total

1.  Genome-wide role of codon usage on transcription and identification of potential regulators.

Authors:  Fangzhou Zhao; Zhipeng Zhou; Yunkun Dang; Hyunsoo Na; Catherine Adam; Anna Lipzen; Vivian Ng; Igor V Grigoriev; Yi Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

Review 2.  The effects of codon bias and optimality on mRNA and protein regulation.

Authors:  Fabian Hia; Osamu Takeuchi
Journal:  Cell Mol Life Sci       Date:  2020-10-30       Impact factor: 9.261

3.  Codon bias confers stability to human mRNAs.

Authors:  Fabian Hia; Sheng Fan Yang; Yuichi Shichino; Masanori Yoshinaga; Yasuhiro Murakawa; Alexis Vandenbon; Akira Fukao; Toshinobu Fujiwara; Markus Landthaler; Tohru Natsume; Shungo Adachi; Shintaro Iwasaki; Osamu Takeuchi
Journal:  EMBO Rep       Date:  2019-09-03       Impact factor: 8.807

4.  Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis.

Authors:  Özgün Le Roux; Nicole L K Pershing; Erin Kaltenbrun; Nicole J Newman; Jeffrey I Everitt; Elisa Baldelli; Mariaelena Pierobon; Emanuel F Petricoin; Christopher M Counter
Journal:  Elife       Date:  2022-09-07       Impact factor: 8.713

Review 5.  Protein synthesis control in cancer: selectivity and therapeutic targeting.

Authors:  Joanna R Kovalski; Duygu Kuzuoglu-Ozturk; Davide Ruggero
Journal:  EMBO J       Date:  2022-03-22       Impact factor: 14.012

Review 6.  Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes.

Authors:  Nayiri M Kaissarian; Douglas Meyer; Chava Kimchi-Sarfaty
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

7.  Mutation bias within oncogene families is related to proliferation-specific codon usage.

Authors:  Hannah Benisty; Marc Weber; Xavier Hernandez-Alias; Martin H Schaefer; Luis Serrano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-16       Impact factor: 11.205

8.  A Crosstalk on Codon Usage in Genes Associated with Leukemia.

Authors:  Supriyo Chakraborty; Durbba Nath; Sunanda Paul; Yashmin Choudhury; Yeongseon Ahn; Yoon Shin Cho; Arif Uddin
Journal:  Biochem Genet       Date:  2020-09-28       Impact factor: 1.890

9.  Synonymous but Not Silent: The Codon Usage Code for Gene Expression and Protein Folding.

Authors:  Yi Liu; Qian Yang; Fangzhou Zhao
Journal:  Annu Rev Biochem       Date:  2021-01-13       Impact factor: 23.643

10.  Adaptation of codon usage to tRNA I34 modification controls translation kinetics and proteome landscape.

Authors:  Xueliang Lyu; Qian Yang; Lin Li; Yunkun Dang; Zhipeng Zhou; She Chen; Yi Liu
Journal:  PLoS Genet       Date:  2020-06-01       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.